ADHD

Latest News



Despite concerns about ADHD stimulant therapy as a gateway for future drug abuse, a new study shows that teens treated with stimulants later and for shorter durations, and those treated with non-stimulant medications, have higher rates of later drug abuse than their peers who have used stimulant therapy longer.

The amount of off-label uses of atypical antipsychotic drugs (AAPs) prescribed for children with attention-deficit/hyperactivity disorder (ADHD) raises questions about the appropriateness of AAPs for this indication.

For Contemporary Pediatrics, Dr Bobby Lazzara explains key findings from a study published in the Journal of Attention Disorders. The study looked at whether there was a correlation between ADHD and frustration tolerance in children.

Children with ADHD are more likely than their peers to consume less water, exercise less, and spend more time staring at screens-all behaviors that may be negatively affecting their ADHD symptoms, according to a new report.

Almost 40% of children and adolescents taking ADHD medications were found to be suffering from bone loss, according to a new report, but researchers are cautioning against changing clinical practices based on these early findings.

Fewer than half of children with attention-deficit/hyperactivity disorder (ADHD) were receiving behavior therapy just before the American Academy of Pediatrics released clinical practice guidelines in 2011, according to the first national study of behavior therapy, medication, and dietary supplements to treat ADHD in children aged 4 to 17 years.

Many pediatricians fail to provide diagnosis and treatment that meet American Academy of Pediatrics guidelines for children with attention-deficit/hyperactivity disorder (ADHD), a recent study reports.

Children with attention-deficit/hyperactivity disorder are more likely than their peers to develop problems with substance abuse, the American Academy of Pediatrics says in a new clinical report that outlines strategies for reducing the risk.

The Centers for Disease Control and Prevention (CDC) has been monitoring the prevalence of diagnosed and medicated attention-deficit/hyperactivity disorder (ADHD) among children aged 4 to 17 years since 1997, and the evolving data show rates for both measures have been rising steadily and more dramatically in recent years.

Computer-based cognitive training programs that claim to improve things such as inattentiveness, hyperactivity, and academic and social success in children with attention-deficit/hyperactivity disorder (ADHD) probably don’t live up to those promises.

An investigation of the combined risks of adolescence, attention-deficit/hyperactivity disorder (ADHD), and driving while engaged in texting or cell phone conversation found that while distractions significantly impair the driving performance of all adolescents, the negative effects of texting are especially prominent in youngsters with ADHD.

With the prevalence of, and prescriptions for, attention-deficit/hyperactivity disorder (ADHD) rising steeply in the past decade, experts are looking at whether current diagnostic practices and definitions are helping or hindering the situation.

Adolescents evolve from child to young adult without the maturity of adulthood to help them navigate the transition, particularly when it comes to the perils of substance use and addiction. Pediatricians who care for transitional-aged youth with substance use disorders have new paradigms that have shown promise for treating addiction and its accompanying comorbidities and for sustaining recovery over time.

To help you stay abreast of research findings about widely used complementary and alternative approaches to the treatment of ADHD, you'll find results from several pivotal studies summarized here.

Before adolescents with attention-deficit/hyperactivity disorder (ADHD) head off to college and away from home, many for the first time, their pediatricians need to initiate frank discussions about how ADHD will affect them both academically and in their daily living and to help them plan a successful transition to what lies ahead.

The first brain wave test to diagnose attention-deficit/hyperactivity disorder (ADHD) will be hitting the market following recent approval by the US Food and Drug Administration (FDA).